| Patents for A61K 9 - Medicinal preparations characterised by special physical form (299,044) |
|---|
| 05/06/2014 | US8716340 Topical composition |
| 05/06/2014 | US8716251 Pharmaceutical formulations containing an SGLT2 inhibitor |
| 05/06/2014 | US8716244 Diaminooxidase-containing pharmaceutical compositions |
| 05/06/2014 | US8716219 Crosslinked protein nanocrystals, crosslinked protein nanoaggregates and method of preparation thereof |
| 05/06/2014 | US8715752 Compositions for increasing human growth hormone levels |
| 05/06/2014 | US8715741 Water-dispersible oral, parenteral, and topical formulations for poorly water soluble drugs using smart polymeric nanoparticles |
| 05/06/2014 | US8715740 Silk nanospheres and microspheres and methods of making same |
| 05/06/2014 | US8715739 Polymer coated microparticles |
| 05/06/2014 | US8715738 Fullerene-silica nanoparticles with improved fluorescence, preparation method thereof and use thereof |
| 05/06/2014 | US8715737 Method to make porous materials and their applications |
| 05/06/2014 | US8715736 Nanoparticle formulations for skin delivery |
| 05/06/2014 | US8715735 Stabilised supersaturated solids of lipophilic drugs |
| 05/06/2014 | US8715734 Amoxicilline instant granulate |
| 05/06/2014 | US8715732 Nucleic acid hydrogel via rolling circle amplification |
| 05/06/2014 | US8715731 Process of reducing the bitter taste of water soluble actives by co-grinding the active with β cyclodextrin |
| 05/06/2014 | US8715730 Therapeutic or prophylactic agent for dyskinesia |
| 05/06/2014 | US8715729 Rapidly disintegrating, solid coated dosage form |
| 05/06/2014 | US8715728 Extended release pellet formulation containing pramipexole or a pharmaceutically acceptable salt thereof |
| 05/06/2014 | US8715727 Tablet for pulsed delivery |
| 05/06/2014 | US8715726 Pharmaceutical composition comprising tramadol and ketoprofen in association |
| 05/06/2014 | US8715725 Secure tracking of tablets |
| 05/06/2014 | US8715724 Tabletting process |
| 05/06/2014 | US8715723 Compositions and methods for delivery of amino-functional drugs |
| 05/06/2014 | US8715722 Capsule with air-vents |
| 05/06/2014 | US8715721 Controlled release hydrocodone |
| 05/06/2014 | US8715720 Cloud mixer and method of minimizing agglomeration of particulates |
| 05/06/2014 | US8715719 Stable chitosan hemostatic implant and methods of manufacture |
| 05/06/2014 | US8715718 Extracellular matrix production from nanoscale substrate |
| 05/06/2014 | US8715714 Uses of rare earth elements for hair improvement |
| 05/06/2014 | US8715713 Solvent cast film sustained release latanoprost implant |
| 05/06/2014 | US8715711 Long-acting injectable moxidectin formulations and novel moxidectin crystal forms |
| 05/06/2014 | US8715710 Semi-solid delivery vehicle and pharmaceutical compositions for delivery of granisetron |
| 05/06/2014 | US8715709 Sustained release intraocular implants and methods for treating ocular neuropathies |
| 05/06/2014 | US8715706 Methods and devices for delivery of pharmaceutical agents within orifices of the body |
| 05/06/2014 | US8715701 Microstructural protein preparations containing adsorbed biologically active substances and their application in medicine and cosmetics |
| 05/06/2014 | US8715699 Amino acid conjugates of quetiapine, process for making and using the same |
| 05/06/2014 | US8715639 Compositions and methods for microbe storage and delivery |
| 05/06/2014 | US8715624 Stable liquid desoximethasone compositions with reduced oxidized impurity |
| 05/06/2014 | US8715623 Pulmonary delivery of aminoglycoside |
| 05/06/2014 | US8715341 Drug-delivery endovascular stent and method of forming the same |
| 05/06/2014 | US8715269 Devices and methods for intraoral controlled drug release |
| 05/06/2014 | US8715268 Administration device having a bolus administration profile controller |
| 05/06/2014 | US8715265 Device and method for combining a treatment agent and a gel |
| 05/06/2014 | US8715235 Dialysis system having disposable cassette and heated cassette interface |
| 05/06/2014 | DE202013011160U1 Ölige Metronidazol-Suspension Oily metronidazole suspension |
| 05/06/2014 | CA2809279C Natural biocomposite powder prepared from pichia pastoris biomass, method of preparation and its use as excipient |
| 05/06/2014 | CA2798924C Improved methods for preparing squalene |
| 05/06/2014 | CA2793525C Method for improving dissolution of anticoagulant agent |
| 05/06/2014 | CA2696063C Immediate release and sustained release ibuprofen dosing form |
| 05/06/2014 | CA2641351C Pharmaceutical compositions containing mixtures of polymers and active agents poorly soluble in water |
| 05/06/2014 | CA2628574C Polypeptide films and methods |
| 05/06/2014 | CA2628305C Jelly composition |
| 05/06/2014 | CA2619834C Stabilized and preserved ketotifen ophthalmic compositions |
| 05/06/2014 | CA2616210C Influenza vaccine compositions |
| 05/06/2014 | CA2612937C Concentrated protein lyophilates, methods, and uses |
| 05/06/2014 | CA2607357C Inhalator capsules |
| 05/06/2014 | CA2578449C Novel powder inhalation preparations based on modified lactose blends that are used as adjuvants |
| 05/06/2014 | CA2566559C Liposomal formulations comprising dihydrosphingomyelin and methods of use thereof |
| 05/06/2014 | CA2561933C Orally administered pharmaceutical composition |
| 05/06/2014 | CA2527756C Immunostimulating agents |
| 05/06/2014 | CA2526150C Treatment of humans with colloidal silver composition |
| 05/06/2014 | CA2522294C Formulations and methods for treating rhinosinusitis |
| 05/06/2014 | CA2514474C Freeze-dried fibrin matrices and methods for preparation thereof |
| 05/06/2014 | CA2488059C Non-polymeric hematopoietic cell clots for delivery of active agents |
| 05/06/2014 | CA2435982C Medicaments |
| 05/02/2014 | DE202014101882U1 Orales Abgabesystem Oral delivery system |
| 05/01/2014 | WO2014066912A1 Polymeric nanoparticles |
| 05/01/2014 | WO2014066898A1 A layer-by-layer approach to co-deliver dna and sirna via aunps: a potential platform for modifying release kinetics |
| 05/01/2014 | WO2014066856A1 Inhalable influenza vaccine compositions and methods |
| 05/01/2014 | WO2014066850A2 Metastable silver nanoparticle composites |
| 05/01/2014 | WO2014066585A1 Compositions and methods for transdermal delivery of amphetamine |
| 05/01/2014 | WO2014066297A1 Nonwoven fiber materials |
| 05/01/2014 | WO2014066225A1 Low toxicity topical active agent delivery system |
| 05/01/2014 | WO2014066208A1 Levodopa formulations for rapid relief of parkinson's disease |
| 05/01/2014 | WO2014066206A1 Reducing inter-patient variability of levodopa plasma concentrations |
| 05/01/2014 | WO2014066053A2 Method of prevention and treatment of clostridium difficile infection |
| 05/01/2014 | WO2014066002A1 Novel self-assembling drug amphiphiles and methods for synthesis and use |
| 05/01/2014 | WO2014065870A1 Bioadhesive films for local and/or systemic delivery |
| 05/01/2014 | WO2014065769A1 Formulations for oral suspensions comprising antibiotics |
| 05/01/2014 | WO2014065751A1 Lyophilized preparations of melphalan flufenamide |
| 05/01/2014 | WO2014065513A1 Ultrasound contrast medium in which nanoparticles containing drug are combined, and preparation method therefor |
| 05/01/2014 | WO2014065427A1 Anagliptin-containing solid pharmaceutical preparation |
| 05/01/2014 | WO2014065390A1 Method for suppressing deposition of menthol whiskers |
| 05/01/2014 | WO2014065245A1 WEAKLY ACIDIC pH-RESPONSIVE PEPTIDE AND LIPOSOME CONTAINING SAME |
| 05/01/2014 | WO2014064717A1 Stable pharmaceutical composition of 5-αζα-2'ρεοχυοτιρινε |
| 05/01/2014 | WO2014064652A2 Stable pharmaceutical composition of peginterferon alpha-2b |
| 05/01/2014 | WO2014064258A1 Compositions and methods for selective delivery of oligonucleotide molecules to cell types |
| 05/01/2014 | WO2014064140A1 Process for the manufacturing of a multilayer drug delivery construct |
| 05/01/2014 | WO2014064030A1 Stable injectable composition containing diclofenac and thiocolchicoside |
| 05/01/2014 | WO2014064028A1 Mglu2/3 antagonists for the treatment of autistic disorders |
| 05/01/2014 | WO2014063923A1 Quinone based nitric oxide donating compounds for ophthalmic use |
| 05/01/2014 | WO2014063662A1 Core-shell particles, preparation process thereof, and composition containing the same |
| 05/01/2014 | WO2014063659A1 Treatment of cancer using a smad3 inhibitor |
| 05/01/2014 | WO2014063602A1 New drug targeting delivery adjuvant |
| 05/01/2014 | WO2014063596A1 Oral formulation for treating diabetes |
| 05/01/2014 | WO2014063549A1 Amphiphilic block copolymer and preparation method thereof and micellar drug-loading system formed by same with antitumor drug |
| 05/01/2014 | WO2014063312A1 Use of salvianolic acid a in prevention and/or treatment of cerebral microvascular thromboembolic disease |
| 05/01/2014 | WO2014063289A1 Anti-cold medicament and preparation method |
| 05/01/2014 | WO2014063288A1 Cold medicament and preparation method |
| 05/01/2014 | WO2014063286A1 Medicament for treatment of common cold and preparation method |